FDA Adverse Event Malfunction Summary report: N

CADD MEDICATION CASSETTE

MDR report key: 21123870 · Received January 10, 2025

Report

Report Number
3012307300-2025-00550
Event Type
Malfunction
Date Received
January 10, 2025
Date of Event
December 1, 2024
Report Date
January 10, 2025
Manufacturer
SMITHS MEDICAL ASD, INC.
Product Code
FPA
PMA / PMN Number
UNKNOWN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

E1 INITIAL REPORTER FACILITY NAME: (B)(6). H3, H6: NO PRODUCT WAS RETURNED. THE REPORTED COMPLAINT COULD NOT BE CONFIRMED. IF THE PRODUCT IS RETURNED THIS COMPLAINT WILL BE REOPENED FOR FURTHER INVESTIGATION. A DEVICE HISTORY RECORD (DHR) REVIEW WAS NOT CONDUCTED AS THERE WAS NO LOT NUMBER PROVIDED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE CASSETTE FROM THE PATIENT¿S LAST ORDER LEAKED MEDICATION. THE PATIENT BEGAN THERAPY WITH REMODULIN (TREPROSTINIL SODIUM, CONCENTRATION 10.0 MG/ML) DELIVERED VIA A SELF-FILLED PUMP. THE CURRENT DOSE WAS REPORTED AS 0.082 G/KG, SELF-FILLED WITH 3 ML PER CASSETTE AT A PUMP RATE OF 38 MCL/HOUR, CONTINUOUS VIA SUBCUTANEOUS (SQ) ROUTE. THERE WAS PATIENT INVOLVEMENT AND UNKNOWN SIGNS OR SYMPTOMS EXPERIENCED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1376658 CADD MEDICATION CASSETTE SET, ADMINISTRATION, INTRAVASCULAR FPA SMITHS MEDICAL ASD, INC. NI

Patients

Seq Age Sex Outcome Treatment
1 71 YR Female ALBUTEROL SULFATE HFA.| ALLOPURINOL.| AMITRIPTYLINE.| ATORVASTATIN CALCIUM.| BUMETANIDE.| CINACALCET.| CLEO INFUSION SET.| CLONIDINE.| FISH OIL.| GABAPENTIN.| GLIPIZIDE.| KETAMINE.| KETOPROFEN.| LECITHIN.| LIDOCAINE.| LOPERAMIDE.| METOPROLOL SUCCINATE.| MULTIVITAMIN.| OXYGEN.| POLOXAMER.| POTASSIUM CHLORIDE.| REMODULIN (TREPROSTINIL SODIUM) SQ ROUTE10.0 MG/ML.| REMUNITY PUMP.| SILDENAFIL CITRATE.| TYLENOL (PARACETAMOL).| WARFARIN SODIUM.| ZYRTEC (CETIRIZINE HYDROCHLORIDE).